Microneedling better than chemical peels for treatment of acne scar
Acne vulgaris is one of most common skin diseases that frequently results in scarring. The scars secondary to acne can lead to physical disfigurements and a profound psychological impact. Therefore early and effective treatment is the best means to minimize and prevent acne scarring. In patients with darker skin tones, current acne scar treatments pose complications, including dyspigmentation, further scarring, and overall unsatisfactory clinical outcomes.
Chemical peels are a common treatment for acne scars. However a Rutgers study has found that microneedling is significantly more effective for patients with dark skin compared to 35% glycolic acid peels for acne scar treatment
Babar Rao, a professor of dermatology and pathology at Robert Wood Johnson Medical School, and fellow researchers randomly assigned 60 patients with acne scars and dark skin-Fitzpatrick Skin Phototype IV to VI-to treatment with either 35 percent glycolic acid chemical peels or microneedling, both administered every two weeks for 12 weeks.
Microneedling is a cosmetic procedure involving tiny, sterilized needles that pierce the skin to stimulate collagen production and reduce scarring. Chemical peels involve applying a solution to the skin that removes the top layers.
Treatment produced an improvement of two points or more on the Goodman and Baron Scarring Grading System in 33 percent of patients who received chemical peels and 73 percent of patients who underwent microneedling.
"Based on the results of this study, patients whose darker skin precludes the use of stronger chemical peels, which can permanently discolor darker skin, should treat acne scars with microneedling," said Rao, the senior author of the study. "For patients with lighter skin who can use stronger peels without risk of discoloration, chemical peels might still be the best option for some."
The researchers concluded that microneedling provided better treatment outcomes compared to 35% glycolic acid peels for acne scar treatment in our patient population with Fitzpatrick Skin Phototypes IV to VI.
Reference:
Fatima Ishfaq, Rohan Shah, Shawana Sharif, Nadia Waqas, Marielle Jamgochian, Babar Rao, PMID: 35783564 PMCID: PMC9239127
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.